Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae-Reference-Cited by-同舟云学术

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

Published:2010-04-27 Issue:1 Volume:3 Page:
ISSN:1756-0500
Container-title:BMC Research Notes
language:en
Short-container-title:BMC Res Notes

Author:

Chaubey Vikas P,Pitout Johann DD,Dalton Bruce,Ross Terry,Church Deirdre L,Gregson Daniel B,Laupland Kevin B

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1756-0500-3-116.pdf

Reference29 articles.

1. Pitout JD, Laupland KB: Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008, 8: 159-166. 10.1016/S1473-3099(08)70041-0.

2. Apisarnthanarak A, Kiratisin P, Mundy LM: Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2008, 29: 671-674. 10.1086/588082.

3. Kang CI, Cheong HS, Chung DR, Peck KR, Song JH, Oh MD, et al: Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis. 2008, 27: 85-88. 10.1007/s10096-007-0401-6.

4. Coque TM, Baquero F, Canton R: Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008, 13:

5. Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R: In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Int J Antimicrob Agents. 2000, 15: 111-118. 10.1016/S0924-8579(00)00152-7.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia;Scientific Reports;2024-07-23

2. Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis;International Journal of Infectious Diseases;2023-03

3. Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation;Antibiotics;2023-02-09

4. Risk Factors for Severe Outcomes in Extended- Spectrum Beta-Lactamase (ESBL) Bacteremia: A Single-center Study;Medicine & Health;2022-12-14

5. Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review;BMC Infectious Diseases;2022-11-21